News Center....FLASH!!!!! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : News Center....FLASH!!!!!

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Instock who wrote (26)	12/29/1997 9:01:00 AM
From: Milk	Read Replies (2) of 115

Watson Pharmaceuticals (NYSE: WPI) Announces FDA Approval for Etodolac Capsules CORONA, Calif., Dec. 29 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI - news) announced today that its wholly owned subsidiary, Royce Laboratories, Inc., has received approval from the Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) to manufacture and market Etodolac 200mg and 300mg capsules. Etodolac is the off-patent equivalent of Wyeth-Ayerst Laboratories' Lodine(R), which is a nonsteroidal anti-inflammatory drug used for the treatment of osteoarthritis and for the management of pain. Shipments are expected to begin in January 1998. Source: biz.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next